A prospective observational study of a cohort of outpatients with an acute medical event and reduced mobility: incidence of symptomatic thromboembolism and description of thromboprophylaxis practices

Bosson, Jean‐Luc; Pouchain, Denis; Bergmann, Jean‐François

doi:10.1111/j.1365-2796.2006.01678.x

Cited by 28 publications

(17 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Thus many of such patients are eligible for VTE prophylaxis even when at home. The duration of such prophylaxis should be individualized according to patients' risk factors [29,30].…”

Section: Discussionmentioning

confidence: 99%

Venous thromboembolism risk stratification in medically-ill hospitalized cancer patients. A comprehensive cancer center experience

Abdel‐Razeq

Hijjawi

Jallad

et al. 2010

J Thromb Thrombolysis

View full text Add to dashboard Cite

Cancer and its treatment are recognized risk factors for VTE. Compliance rate with published VTE prophylaxis guidelines is low. Decision on when to offer prophylaxis for hospitalized cancer patients is difficult to make. This paper describes current clinical practice in offering VTE prophylaxis to hospitalized cancer patients. Prophylaxis rate and rate of VTE will be correlated with the risk level. We prospectively followed all consecutive adult cancer patients admitted to medical units over a 5-month period. Caprini risk assessment model, with some modifications, was utilized to determine risk of VTE. Six hundred and six patients (51% males, median age 52 years, range 18-91) were included. Reasons for admission included infections (25%), chemotherapy (22%) and palliative care (10%). In addition to cancer, the most frequently encountered risk factors for VTE were: Immobilization (35%), age > 60 years (31%) and body mass index > 30 in (20%). Patients were grouped according to their total risk score: low (9%), moderate (44%) and high risk (47%). VTE prophylaxis rate was 55.1% for the whole study group. Following discharge, patients were followed for 60 days. The incidence of VTE was 3.4% in the moderate and 4.2% in the high risk groups, while none in the low risk group developed VTE. Many additional risk factors for VTE are usually encountered in hospitalized cancer patients. Cancer alone may not be an enough reason for VTE prophylaxis. Risk assessment model able to stratify patients into different risk categories will simplify decision making and enhance VTE prophylaxis rate.

show abstract

“…Thus many of such patients are eligible for VTE prophylaxis even when at home. The duration of such prophylaxis should be individualized according to patients' risk factors [29,30].…”

Section: Discussionmentioning

confidence: 99%

Venous thromboembolism risk stratification in medically-ill hospitalized cancer patients. A comprehensive cancer center experience

Abdel‐Razeq

Hijjawi

Jallad

et al. 2010

J Thromb Thrombolysis

View full text Add to dashboard Cite

show abstract

“…ical condition reducing mobility for at least 48 h. 115 Anticoagulant prophylaxis was administered to 35% of patients. The study found a 1.2% incidence of symptomatic VTE in the 3 weeks after the onset of the acute condition.…”

Section: Risk Of Vtementioning

confidence: 99%

Prevention of VTE in Nonsurgical Patients

Falck‐Ytter

Francis

Johanson

et al. 2012

Chest

1,770

485

View full text Add to dashboard Cite

“…Plusieurs éléments peuvent être soulevés pour expliquer cette situation. D'abord, les médecins généralistes pourraient être moins habitués à prescrire la prophylaxie car une proportion plus faible de leurs patients présentent un risque significatif (seulement 32,7 % comparativement à 54,2 % pour les autres patients médicaux ; p = 0,01) ; cela est également retrouvé dans l'étude d'évaluation de l'incidence des événements thromboemboliques veineux et des modalités ambulatoires de prévention du risque thromboembolique en médecine générale (Etape) [11], dans laquelle le taux d'événement thromboembolique était très faible, alimentant l'idée selon laquelle l'exposition des généralistes à ce problème demeure limitée. De plus, les patients des spécialités médi-cales sont évalués par un plus grand nombre de médecins et de résidents, ce qui augmente les chances qu'un membre de l'équipe pense à la prophylaxie.…”

Section: Patient Et Méthodesunclassified

Évaluation de l’utilisation de la thromboprophylaxie chez les patients hospitalisés dans un centre hospitalier universitaire : un modèle applicable d’évaluation de la qualité de l’acte. Une revue de 320 patients hospitalisés

Lanthier¹,

Bechard²,

Viens³

et al. 2011

Journal des Maladies Vasculaires

View full text Add to dashboard Cite

A prospective observational study of a cohort of outpatients with an acute medical event and reduced mobility: incidence of symptomatic thromboembolism and description of thromboprophylaxis practices

Cited by 28 publications

References 28 publications

Venous thromboembolism risk stratification in medically-ill hospitalized cancer patients. A comprehensive cancer center experience

Venous thromboembolism risk stratification in medically-ill hospitalized cancer patients. A comprehensive cancer center experience

Prevention of VTE in Nonsurgical Patients

Évaluation de l’utilisation de la thromboprophylaxie chez les patients hospitalisés dans un centre hospitalier universitaire : un modèle applicable d’évaluation de la qualité de l’acte. Une revue de 320 patients hospitalisés

Contact Info

Product

Resources

About